Up Next
Back to Show
PBS News Hour
What we know about remdesivir study and COVID-19 antibodies
Testing, both for active cases of COVID-19 and for antibodies indicating prior exposure to the disease, will be critical to resuming economic activity. In addition, scientists are racing to develop therapies for people who do get infected -- especially those who become seriously ill. Science correspondent Miles O’Brien joins Judy Woodruff to discuss the latest on COVID-19 testing and treatment.
Support Provided By
57:46
February 18, 2026 - PBS News Hour full episode
57:46
February 17, 2026 - PBS News Hour full episode
57:46
February 16, 2026 - PBS News Hour full episode
57:46
February 13, 2026 - PBS News Hour full episode
57:46
February 12, 2026 - PBS News Hour full episode
57:46
February 11, 2026 - PBS News Hour full episode
57:46
February 10, 2026 - PBS News Hour full episode
56:45
February 9, 2026 - PBS News Hour full episode
57:46
February 6, 2026 - PBS News Hour full episode
57:46
February 5, 2026 - PBS News Hour full episode
56:44
February 4, 2026 - PBS News Hour full episode
57:46
February 3, 2026 - PBS News Hour full episode